ArticleJCO precision oncology2022

SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors.

Hiroki Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.